GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » ROE % Adjusted to Book Value

Oxford BioDynamics (Oxford BioDynamics) ROE % Adjusted to Book Value : -53.47% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics ROE % Adjusted to Book Value?

Oxford BioDynamics's ROE % for the quarter that ended in Sep. 2023 was -202.11%. Oxford BioDynamics's PB Ratio for the quarter that ended in Sep. 2023 was 3.78. Oxford BioDynamics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was -53.47%.


Oxford BioDynamics ROE % Adjusted to Book Value Historical Data

The historical data trend for Oxford BioDynamics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics ROE % Adjusted to Book Value Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -6.09 -369.38 -68.01

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.24 -19.40 -443.76 -17.86 -53.47

Competitive Comparison of Oxford BioDynamics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Oxford BioDynamics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's ROE % Adjusted to Book Value falls into.



Oxford BioDynamics ROE % Adjusted to Book Value Calculation

Oxford BioDynamics's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-257.06% / 3.78
=-68.01%

Oxford BioDynamics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-202.11% / 3.78
=-53.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (Oxford BioDynamics) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (Oxford BioDynamics) Headlines

From GuruFocus